FDA Inspection 1117471 — James F. Trotter, M.D.
The FDA completed an inspection of James F. Trotter, M.D. on Jan 16, 2020 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 16, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dallas, TX (United States)
Additional details
Clinical Investigator (CI)